使用LanM酶修改E.coli中的葡萄糖样1和2
Camilla K Larsen1,2, Peter Lindquist3, Mette Rosenkilde3
1Department of Biological and Chemical Engineering, Aarhus University, 8000, Aarhus C, Denmark.
概括
研究人员利用天然改酶将D-alanine安装在类似葡萄糖 (GLP) 1和2中,从而增强它们的制药特性. 前体的设计影响了修改结果.
科学领域:
- 生物化学 生物化学
- 类化学 类化学
- 合成生物学 合成生物学
背景情况:
- 生物活性通常需要修改以改善稳定性和功效等药物特性.
- 核糖体合成和翻译后修饰 (RiPPs) 使用特定的酶和领导进行选择性修饰.
- 葡萄糖样 (GLP) 1和2是具有治疗潜力的关键激素.
研究的目的:
- 使用RiPP机器研究D-alanine在GLP-1和GLP-2中的翻译后安装.
- 探索前体的设计如何影响改的选择性和模式.
- 为了利用天然的酶系统进行工程疗法.
主要方法:
- 利用来自RiPP通路的领导和相关酶.
- 为GLP-1和GLP-2开发的工程前体.
- 研究了D-alanine的特定部位的结合.
- 分析了基于前体设计的修改模式.
主要成果:
- 成功证明了D-alanine在GLP-1和GLP-2中的翻译后安装.
- 展示了领导和酶引导修改到特定位置的能力.
- 确定前体的修改可以调节由此产生的修改模式.
- 提供了对RiPP系统内的酶基质相互作用的见解.
结论:
- 领导指导的酶系统为选择性改提供了强大的工具.
- 在GLP-1和GLP-2中工程D-alanine的整合是可行的,并且可以通过前体设计来调节.
- 这种方法对开发具有增强性质的下一代基于的治疗方法具有前景.
更多相关视频
11:25Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
6.6K
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
15.5K
相关概念视频
Glucagon-like Receptor Agonists
319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Insulin: Biosynthesis, Chemistry, and Preparation
374
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
374
